QuidelOrtho Corporation (QDEL)

NASDAQ: QDEL · Real-Time Price · USD

33.65

+0.14 (0.40%)

At close: Jan 9, 2026, 4:00 PM EST

33.59

-0.06 (-0.17%)

After-hours: Jan 9, 2026, 5:30 PM EST

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2021
Period Ending	Sep '25 Sep 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	2014 - 2021
North America Revenue	1.50B	1.62B	Log In	Log In	Log In	Upgrade
EMEA Revenue	353.90M	335.80M	Log In	Log In	Log In	Upgrade
China Revenue	329.90M	325.00M	Log In	Log In	Log In	Upgrade
Other Geographies Revenue	532.20M	502.30M	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.71B	2.78B	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2021
Period Ending	Sep '25 Sep 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	2014 - 2021
Labs Revenue	1.47B	1.43B	Log In	Log In	Log In	Upgrade
Immunohematology Revenue	539.50M	522.60M	Log In	Log In	Log In	Upgrade
Donor Screening Revenue	60.60M	115.50M	Log In	Log In	Log In	Upgrade
Transfusion Medicine Revenue	600.10M	638.10M	Log In	Log In	Log In	Upgrade
Point of Care Revenue	613.20M	694.10M	Log In	Log In	Log In	Upgrade
Molecular Diagnostics Revenue	24.80M	24.00M	Log In	Log In	Log In	Upgrade
Revenue (Other)	3.70M	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.71B	2.78B	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2021
Period Ending	Sep '25 Sep 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022	2014 - 2021
North America Adjusted EBITDA	-	892.10M	Log In	Log In	Log In	Upgrade
EMEA Adjusted EBITDA	-	46.50M	Log In	Log In	Log In	Upgrade
China Adjusted EBITDA	-	130.50M	Log In	Log In	Log In	Upgrade
Other Geographies Adjusted EBITDA	-	133.50M	Log In	Log In	Log In	Upgrade
Corporate Adjusted EBITDA	-	-659.70M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	-953.30M	-1.96B	Log In	Log In	Log In	Upgrade

Updated Sep 28, 2025. Data Source: Fiscal.ai.